Uscid est ad quis et lam sitatium commoloribus solupta illaborum doloria alisci dioribus si quis porereh enianimus mollam, quo maxim quis ma senimus, alit,Deles etusapici am, inusdae commodi cupiderro doluptas acipsap elignatio omnihilla inihiliciu Denihit doluptamus ut ped ut eatinie ndandem. Quae. Olut exerios dipsum nis
FOR US HEALTHCARE PROFESSIONALS ONLY
embecta, formerly part of BD
Discovery. Diagnostics. Delivery.
Can be accessed on our Customer Learning Portal. The e-learning courses offer detailed and solution focused training to help better understand how to solve for common scenarios.
Discovery. Diagnostics. Delivery.
Can be accessed on our Customer Learning Portal. The e-learning courses offer detailed and solution focused training to help better understand how to solve for common scenarios.
Experts from around the globe describe the intersection between patient and healthcare worker safety, focusing on techniques to improve both occupational and public health.
Webinar Objectives:
- Describe the current global impact of bloodborne disease
- Describe occupational exposure incidents for needlesticks and sharps injuries
- Define safety as a function of focus for both patient and health worker, to reduce overall bloodborne disease
- Provide guidance on the importance of prevention programs including use of safer medical devices, immunization/vaccination programs, and safe clinical practices
- Illustrate an effective pathway for reporting exposure incidents and injuries
- Define processes for post-exposure medical treatment and prophylaxis
- Share global experiences from key stakeholders responsible for sharps safety and public health programs around the world
Save Your Seat
How can your patients benefit from proper injection technique?
In a study of patients with diabetes who inject insulin, patients educated on proper injection technique (including using a new needle for every injection, rotating injection sites, and shifting to a 4mm or 5mm needle) experienced a 1% reduction in A1C at 6 months.5‡
How can your patients benefit from maintaining a long-term reduction in their A1C?
The landmark United Kingdom Prospective Diabetes Study (UKPDS) reported an association between maintenance of glycemic control in patients with newly diagnosed diabetes and the risk of developing long-term complications; for each 1% reduction in A1C, there was a 37% risk reduction for microvascular complications, including retinopathy, nephropathy, and neuropathy.6§
Take a moment to talk to your patients about the reasons to use a new pen needle
Needles are no longer sterile after use2
Reuse may increase risk of injection pain and bleeding3,7¶
Encourage your patients to use a new needle with every injection by reminding them to check their needle supply
Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas vestibulum tortor quam.
Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas vestibulum tortor quam.
Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas vestibulum tortor quam.
Video title here
Let's have a conversation
Hospitals and healthcare facilities
BD is a market leader in hospital products that can reduce the incidence of sharps injuries and exposure to bloodborne pathogens. Patient safety has been a focus of BD innovation for years, not only in the United States but also around the world. Working closely with organizations like the International Safety Center (EPINet) is an important part of our efforts to keep patients and workers safe.
Safety syringes and needles >>
Hazardous drug safety >>
Infection prevention >>
Diabetes self-care goes beyond healthy eating and activities
You may know using a new needle for every injection is recommended as part of proper injection technique, but did you know that proper injection technique may help lower A1C?2-5†‡
Ensure your patients have enough pen needles or insulin syringes
-
Remind your patients of the importance of using a new needle with each injection
-
Ask your patients to check their needle supply every time they refill their insulin
Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas vestibulum tortor quam.
Store Tab
360° rotation knob is effectively sized, contoured and located to enable easy instrument rotation.
360° rotation knob is effectively sized
360° rotation knob is effectively sized
360° rotation knob is effectively sized
Store Tab
360° rotation knob is effectively sized, contoured and located to enable easy instrument rotation.
360° rotation knob is effectively sized
360° rotation knob is effectively sized
360° rotation knob is effectively sized
Hospitals and healthcare facilities
BD is a market leader in hospital products that can reduce the incidence of sharps injuries and exposure to bloodborne pathogens. Patient safety has been a focus of BD innovation for years, not only in the United States but also around the world. Working closely with organizations like the International Safety Center (EPINet) is an important part of our efforts to keep patients and workers safe.
Safety syringes and needles >>
Hazardous drug safety >>
Infection prevention >>
Hospitals and healthcare facilities
BD is a market leader in hospital products that can reduce the incidence of sharps injuries and exposure to bloodborne pathogens. Patient safety has been a focus of BD innovation for years, not only in the United States but also around the world. Working closely with organizations like the International Safety Center (EPINet) is an important part of our efforts to keep patients and workers safe.
Safety syringes and needles >>
Hazardous drug safety >>
Infection prevention >>
Uscid est ad quis et lam sitatium commoloribus solupta illaborum doloria alisci dioribus si quis porereh enianimus mollam, quo maxim quis ma senimus, alit,Deles etusapici am, inusdae commodi cupiderro doluptas acipsap elignatio omnihilla inihiliciu Denihit doluptamus ut ped ut eatinie ndandem. Quae. Olut exerios dipsum nis
Not all pen needles are created equal
Get information about a redesigned pen needle with a contoured base you may want to consider for your patients.
Pellentesque habitant morbi
- Tristique senectus et netus et malesuada
- Tristique senectus et netus et malesuada
- Tristique senectus et netus et malesuada
- Tristique senectus et netus et malesuada
Let's have a conversation
*
13,289 patients with diabetes who inject insulin participated in an ITQ survey. 38.8% of the 2,711 patients using insulin syringes reported needle reuse. 55.8% of the 11,961 patients using pen needles reported needle reuse.
†
13,289 insulin-injecting patients from 423 centers in 42 countries participated in a survey. Incorrect injection site rotation, years taking insulin, and pen needle reuse were associated with lipohypertrophy (all significant at P<0.05).
‡
Based on an RCT pilot study. 116 patients with diabetes (mostly type 2 diabetes mellitus) on insulin were randomized into 3 groups to assess the change in A1C over 6 months. Groups 1 and 2 received structured injection training and group 3 was the control. Baseline A1C for all groups was similar (mean: 8.5 to 8.8% [±1.4 to 1.9%]). At 6 months, mean [95% CI] reductions in A1C from baseline were significant in groups 1 and 2 (-1.00% [-1.3 to -0.6%] and -1.00% [-1.4 to -0.7%], respectively; P<0.001 for both). The mean A1C reduction in group 3 was not significant (-0.02% [-1.2 to 1.6%]).
§
UKPDS 35, a prospective observational study of 3642 patients with newly diagnosed type 2 diabetes mellitus. A1C was measured as an updated mean and controlled for confounding variables. Risk reduction for microvascular endpoints was 37% per 1% reduction in A1C concentration [(P<0.0001) (95% CI, 33% to 41%)]. Glucose-lowering medications like SGLT2 inhibitors and GLP-1 receptor agonists were not available at the time of the study. Epidemiological associations of therapeutic lowered A1C cannot necessarily be transferred to clinical practice.
||
116 patients with diabetes on insulin were randomized to 3 intervention groups to assess the change from baseline in A1C at 6 months following structured injection technique training. Adequate supply is defined as receiving needles sufficient for each injection.
¶
A causal relationship has not been established. 13,289 insulin-injecting patients participated in a survey. Increased injection pain and needle reuse were assessed through a questionnaire and lipohypertrophy (LH) was assessed through a questionnaire and HCP assessment using visual and palpation methods. Logistic regression analysis was used to find the association between pen needle reuse and LH (P=0.02). Pain was associated with needle reuse as higher rates of injection pain were observed the more times a needle was reused (P<0.001).
#
A causal relationship has not been established. 13,289 insulin-injecting patients participated in a survey. Needle reuse was assessed through a questionnaire and lipohypertrophy (LH) was assessed through a questionnaire and HCP assessment using visual and palpation methods. Logistic regression analysis was used to find the association between pen needle reuse and LH (P=0.02).
**
430 patients with diabetes who had been injecting insulin for at least 1 year were observed on their injection technique (ie, site rotation, area of injection, frequency of needle/syringe reuse) as well as the presence of lipohypertrophy (LH). 49% of patients with LH reported having episodes of glycemic variability vs 7% without LH (P<0.01). “Glycemic variability” was defined as oscillations of blood glucose values from <60 to >250 mg/dL at least 3 times a week in an unpredictable and unexplained fashion.
REFERENCES
-
Frid AH, Hirsch LJ, Menchior AR, Morel DR, Strauss KW. Worldwide injection technique questionnaire study: population parameters and injection practices. Mayo Clin Proc. 2016;91(9):1212-1223.
-
Frid AH, Kreugel G, Grassi G, et al. New insulin delivery recommendations. Mayo Clin Proc. 2016;91(9):1231-1255.
-
Frid AH, Hirsch LJ, Menchior AR, Morel DR, Strauss KW. Worldwide injection technique questionnaire study: injecting complications and the role of the professional. Mayo Clin Proc. 2016;91(9):1224-1230.
-
American Diabetes Association. Standards of medical care in diabetes—2022. Diabetes Care. 2022;45(suppl 1):S1-S264.
-
Misnikova IV, Gubkina VA, Lakeeva TS, Dreval AV. A randomized controlled trial to assess the impact of proper insulin injection technique training on glycemic control. Diabetes Ther. 2017;8(6):1309-1318.
-
Stratton IM, Adler AI, Neil HA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000;321(7258):405-412.
-
Subcutaneous injection guidelines for the education of persons with diabetes—2019. ADCES Practice Paper 2019. https://www.diabeteseducator.org/docs/default-source/practice/practice-documents/practice-papers/adces-subcutaneous-injection-guidelines-for-the-education-of-persons-with-diabetes-final-4-1-20.pdf?sfvrsn=4. Accessed October 4, 2021.
-
Blanco M, Hernández MT, Strauss KW, Amaya M. Prevalence and risk factors of lipohypertrophy in insulin-injecting patients with diabetes. Diabetes Metab. 2013;39(5):445-453.
embecta, formerly part of BD, is now one of the largest pure-play diabetes management companies in the world. This singular focus allows us to leverage our nearly 100-year legacy in insulin delivery, while empowering people with diabetes to live their best life through innovative solutions, partnerships, and the passion of over 2,000 employees around the globe.
- Follow Us
-
-
.svg "X Logo"){kind=icon}
embecta, formerly part of BD. embecta and the embecta logo are trademarks of Embecta Corp. All other trademarks are the property of their respective owners. © 2024 Embecta Corp. All rights reserved.